Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP vs Hyaluronic Acid for Knee Osteoarthritis
NCT05824806Phase 3Not yet recruiting
- Sponsor
- Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad
- Start
- Aug 2024
- Primary completion
- Aug 2025
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of platelet-rich plasma in knee osteoarthritis (OA) (3 arms), sponsored by Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad. Primary endpoints: Western Ontario and McMaster Universities Arthritis Index at 1 year, Knee Society Score at 1 year and 1 more. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05824806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05824806.